StockData
Elanco Animal Health Inc logo

Elanco Animal Health Inc (ELAN) stock

ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$26.70+0.85 (+3.29%)

Close on Nov 18, 2026Market cap $13.34BP/E –Yield –

Elanco Animal Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Elanco Animal Health's revenue for the twelve months ending Jun 30, 2026 was $5.02B, up 12.0% year over year. For fiscal 2025 it was $4.72B, up 6.2% from the year before. The highest annual figure on record is $4.76B in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.72B+6.2%
FY2024Dec 31, 2024$4.44B+0.5%
FY2023Dec 31, 2023$4.42B+0.1%
FY2022Dec 31, 2022$4.41B-7.4%
FY2021Dec 31, 2021$4.76B+45.6%
FY2020Dec 31, 2020$3.27B+6.5%
FY2019Dec 31, 2019$3.07B+0.1%
FY2018Dec 31, 2018$3.07B+6.2%
FY2017Dec 31, 2017$2.89B-0.8%
FY2016Dec 31, 2016$2.91B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.37B+10.2%
Q1 FY2026Mar 31, 2026$1.37B+14.9%
Q4 FY2025Dec 31, 2025$1.14B+12.2%
Q3 FY2025Sep 30, 2025$1.14B+10.4%
Q2 FY2025Jun 30, 2025$1.24B+4.8%
Q1 FY2025Mar 31, 2025$1.19B-1.0%
Q4 FY2024Dec 31, 2024$1.02B-1.4%
Q3 FY2024Sep 30, 2024$1.03B-3.6%
Q2 FY2024Jun 30, 2024$1.18B+12.0%
Q1 FY2024Mar 31, 2024$1.21B-4.1%
Q4 FY2023Dec 31, 2023$1.04B+5.1%
Q3 FY2023Sep 30, 2023$1.07B+4.1%
Q2 FY2023Jun 30, 2023$1.06B-10.0%
Q1 FY2023Mar 31, 2023$1.26B+2.5%
Q4 FY2022Dec 31, 2022$985.00M-11.4%
Q3 FY2022Sep 30, 2022$1.03B-9.3%
Q2 FY2022Jun 30, 2022$1.18B-8.1%
Q1 FY2022Mar 31, 2022$1.23B-1.4%
Q4 FY2021Dec 31, 2021$1.11B-2.4%
Q3 FY2021Sep 30, 2021$1.13B+27.1%
Q2 FY2021Jun 30, 2021$1.28B+118.1%
Q1 FY2021Mar 31, 2021$1.24B+88.9%
Q4 FY2020Dec 31, 2020$1.14B+44.8%
Q3 FY2020Sep 30, 2020$890.00M+15.4%
Q2 FY2020Jun 30, 2020$586.00M-25.0%
Q1 FY2020Mar 31, 2020$658.00M-10.0%
Q4 FY2019Dec 31, 2019$787.00M-1.5%
Q3 FY2019Sep 30, 2019$771.30M+1.3%
Q2 FY2019Jun 30, 2019$781.60M+1.5%
Q1 FY2019Mar 31, 2019$731.10M-0.7%
Q4 FY2018Dec 31, 2018$799.30M+6.0%
Q3 FY2018Sep 30, 2018$761.10M+9.2%
Q2 FY2018Jun 30, 2018$770.20M+5.1%
Q1 FY2018Mar 31, 2018$736.20M+4.5%
Q4 FY2017Dec 31, 2017$754.30M–
Q3 FY2017Sep 30, 2017$697.10M–
Q2 FY2017Jun 30, 2017$732.80M–
Q1 FY2017Mar 31, 2017$704.80M–

More Elanco Animal Health figures

See a number that looks wrong?